[FULC] QoQ Quarter Result on 30-Sep-2021 [#Q2]

Stock
[FULC] Fulcrum Therapeutics, Inc.
Announcement Date
04-Nov-2021
Financial Year
2021
Quarter
30-Sep-2021 [#Q2]
Profit Trend
QoQ- -5.44%
YoY- -9.25%
Quarter Report
FULC's Result
FULC's Financial Summary
View:
Show?
Quarter Result
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
Revenue 1,882 2,592 5,058 4,935 4,381 4,789 4,225 -41.76%
PBT -34,070 -25,928 -23,484 -20,716 -19,648 -16,999 -17,720 54.80%
Tax -24 -70 -621 19 -28 0 -733 -89.82%
NP -34,070 -25,858 -23,484 -20,716 -19,648 -16,999 -17,720 54.80%
Tax Rate - - - - - - - -
Total Cost 35,952 28,450 28,542 25,651 24,029 21,788 21,945 39.09%
Ratio Analysis
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
NP Margin -1,810.31 -997.61 -464.29 -419.78 -448.48 -354.96 -419.41 165.81%
Per Share
30/06/22 31/03/22 31/12/21 30/09/21 30/06/21 31/03/21 31/12/20 CAGR
EPS -0.83 -0.64 -0.58 -0.57 -0.60 -0.54 -0.64 18.97%
EPS Diluted -0.83 -0.64 -0.58 -0.57 -0.60 -0.54 -0.64 18.97%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.